Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.

Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.
New research by Professor Seungpyo Hong and his collaborators demonstrates improved methods for capturing circulating tumor cells on clinical samples for the first time.
Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both entrepreneurs and academic researchers, and they’re both targeting cancer.
Capio Biosciences, Inc., a cancer diagnostic biotech startup, is partnering with the University of Wisconsin–Madison on research that will further develop novel technology in cancer detection. The Research Service Agreement (RSA) will support the research of …